Lambert-Eaton Myasthenic Syndrome

Download PDF

Recent Publications on Lambert-Eaton Myasthenic Syndrome:
Chapter 9 The Lambert-Eaton myasthenic syndrome. Lafora disease (LD) is the most severe form of Progressive Myoclonus...	18th July, 2008	Duke University Medical School, Durham, NC, USA.	Handb Clin Neurol. 2008;91:273-83. DOI Direct Link
Using immunoglobulins in muscular disease treatment. BACKGROUND: Intravenous immunoglobulins (IVIg) have been proven in the...	11th July, 2008	Department of Neurology, Hannover Medical School, Carl-Neuberg-Street 1,	Expert Opin Biol Ther. 2008 Aug;8(8):1143-50. DOI Direct Link
Lambert-Eaton syndrome with large-cell neuroendocrine carcinoma of the lung. Lambert-Eaton syndrome (LES) is an immune-mediated disorder of the...	10th July, 2008	The Neurological Institutes, University Hospitals Case Medical Center,	Muscle Nerve. 2008 Jun;37(6):786-9. DOI Direct Link
Lambert-Eaton myasthenic syndrome in childhood. Lambert-Eaton myasthenic syndrome (LEMS) is a rare autoimmune disorder of...	1st July, 2008	Department of Neurology, Medical University of Warsaw, Poland.	Eur J Paediatr Neurol. 2008 Jun 26;. DOI Direct Link
Lambert-Eaton Myasthenic Syndrome: Tumor versus Nontumor Forms. Half the patients with Lambert-Eaton myasthenic syndrome (LEMS) have a...	24th June, 2008	Department of Neurology, K5-Q, Leiden University Medical Center, PO Box	Ann N Y Acad Sci. 2008 Jun;1132:129-34. DOI Direct Link
→View more research publications.

Lambert-Eaton Myasthenic Syndrome Clinical Trials:
Treatment of Lambert-Eaton Syndrome With 3,4 DAP	Lambert Eaton Myasthenic Syndrome

Lambert-Eaton Myasthenic Syndrome Patents:
US Patent No.	Title
6936688	Human chemokine beta-10 mutant polypeptides
7063950	Nucleic acids encoding human calcium channel and methods of use thereof
7067512	Substituted 1,4-benzodiazepines and uses thereof
7070803	Controlled release pharmaceutical composition for oral use containing midodrine and/or active metabolite, desglymidodrine
7078186	Apoptosis related polynucleotides, polypeptides, and antibodies
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Lambert-Eaton Myasthenic Syndrome scientists - we have details of around 66 individuals working on Lambert-Eaton Myasthenic Syndrome .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.